UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects

European journal of clinical pharmacology, 2014-10, Vol.70 (10), p.1159-1172

Wehling, Martin

2014

Volltextzugriff (PDF)

Systematic review of anticholinergic risk scales in older adults

European journal of clinical pharmacology, 2013-07, Vol.69 (7), p.1485-1496

2013

Volltextzugriff (PDF)

Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections

European journal of clinical microbiology & infectious diseases, 2014-08, Vol.33 (8), p.1311-1322

2014

Volltextzugriff (PDF)

Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis

Advances in therapy, 2013-10, Vol.30 (10), p.870-884

2013

Volltextzugriff (PDF)

Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals

European journal of clinical pharmacology, 2011-11, Vol.67 (11), p.1175-1188

2011

Volltextzugriff (PDF)

Hepatotoxicity from green tea: a review of the literature and two unpublished cases

European journal of clinical pharmacology, 2009-04, Vol.65 (4), p.331-341

2009

Volltextzugriff (PDF)

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Investigational new drugs, 2014-02, Vol.32 (1), p.178-187

2014

Volltextzugriff (PDF)

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

Cancer chemotherapy and pharmacology, 2012-05, Vol.69 (5), p.1229-1240

2012

Volltextzugriff (PDF)

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2013-02, Vol.71 (2), p.523-530

2013

Volltextzugriff (PDF)

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2012-09, Vol.70 (3), p.399-405

2012

Volltextzugriff (PDF)

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.357-371

2010

Volltextzugriff (PDF)

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

Cancer chemotherapy and pharmacology, 2011-07, Vol.68 (1), p.157-164

2011

Volltextzugriff (PDF)

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.765-775

2013

Volltextzugriff (PDF)

Ipilimumab associated hepatitis: imaging and clinicopathologic findings

Investigational new drugs, 2013-08, Vol.31 (4), p.1071-1077

2013

Volltextzugriff (PDF)

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma

Investigational new drugs, 2014-12, Vol.32 (6), p.1246-1257

2014

Volltextzugriff (PDF)

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications

European journal of clinical pharmacology, 2014-07, Vol.70 (7), p.849-857

2014

Volltextzugriff (PDF)

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

Investigational new drugs, 2014-08, Vol.32 (4), p.670-681

2014

Volltextzugriff (PDF)

A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients

Cancer chemotherapy and pharmacology, 2013-06, Vol.71 (6), p.1521-1530

2013

Volltextzugriff (PDF)

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

Cancer chemotherapy and pharmacology, 2013-07, Vol.72 (1), p.139-146

2013

Volltextzugriff (PDF)

Prevalence of polypharmacy in a Scottish primary care population

European journal of clinical pharmacology, 2014-05, Vol.70 (5), p.575-581

2014

Volltextzugriff (PDF)

A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2014-08, Vol.74 (2), p.277-282

2014

Volltextzugriff (PDF)

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.663-670

2013

Volltextzugriff (PDF)

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Pharmaceutical research, 2012-10, Vol.29 (10), p.2860-2873

2012

Volltextzugriff (PDF)

A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors

Cancer chemotherapy and pharmacology, 2013-04, Vol.71 (4), p.1041-1050

2013

Volltextzugriff (PDF)

Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study

European journal of clinical pharmacology, 2011-05, Vol.67 (5), p.507-519

2011

Volltextzugriff (PDF)

1 – 25 von 9.946

Suche als RSS-Feed

Aktive Filter

SpracheRussisch

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaAged

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(9.925)
Mit Volltextzugriff
(9.836)

Publikationsform

Artikel
(9.946)

Sprache

Englisch
(9.946)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects

Systematic review of anticholinergic risk scales in older adults

Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections

Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis

Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals

Hepatotoxicity from green tea: a review of the literature and two unpublished cases

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

Ipilimumab associated hepatitis: imaging and clinicopathologic findings

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

Prevalence of polypharmacy in a Scottish primary care population

A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors

Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study

Aktive Filter

Suchergebnisse filtern